Monaco Asset Management’s Novavax NVAX Stock Holding History

Monaco Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.44M	Sell	577,464 -120,136	-17%	-$1.08M	0.43%	28
2026 Q1	$5.68M	Sell	697,600 -347,400	-33%	-$3.15M	1.05%	27
2025 Q4	$7.02M	Buy	1,045,000 +645,000	+161%	+$4.86M	1.22%	26
2025 Q3	$3.47M	Buy	400,000 +170,000	+74%	+$1.32M	0.21%	46
2025 Q2	$1.45M	Sell	230,000 -60,000	-21%	-$397K	0.25%	53
2025 Q1	$1.86M	Buy	290,000 +5,000	+2%	+$41.3K	0.38%	34
2024 Q4	$2.29M	Buy	285,000 +222,500	+356%	+$2.14M	0.33%	39
2024 Q3	$789K	Sell	62,500 -22,500	-26%	-$291K	0.11%	60
2024 Q2	$1.08M	Sell	85,000 -103,900	-55%	-$1.05M	0.17%	42
2024 Q1	$903K	Buy	188,900 +121,751	+181%	+$565K	0.27%	42
2023 Q4	$322K	Buy	67,149 +37,149	+124%	+$227K	0.09%	69
2023 Q3	$217K	Sell	30,000 -34,371	-53%	-$275K	0.06%	67
2023 Q2	$478K	Buy	+64,371	New	+$506K	0.13%	56

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Monaco Asset Management's NVAX Position: Q2 2026 in Review

Monaco Asset Management reduced its Novavax (NVAX) stake by 17% in Q2 2026, selling an estimated $1.08M and leaving 577,464 shares worth $5.44M. The position accounts for 0.43% of the portfolio, ranked #28.

Monaco Asset Management first reported a position in NVAX in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.02M in Q4 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Monaco Asset Management held 577,464 shares of Novavax worth $5.44M as of Q2 2026.
Monaco Asset Management sold 120,136 Novavax shares in Q2 2026, an estimated $1.08M.
Novavax made up 0.43% of Monaco Asset Management's portfolio in Q2 2026, its #28 holding.
Monaco Asset Management first reported a position in Novavax in Q2 2023 and has held it in 13 quarters since.
Monaco Asset Management's Novavax position peaked at $7.02M in Q4 2025.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.